PierianDx is catalyzing global adoption of genomic sequencing in healthcare
PierianDx has raised $30.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2021.
PierianDx's investors include OrbiMed, RTI International, Album VC, ARUP Laboratories, ATW Partners.
PierianDx is headquartered in St Louis, United States.
PierianDx is catalyzing global adoption of genomic sequencing in healthcare
PierianDx is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"PierianDx — Funding & Investors." VCBacked, November 2, 2021, https://www.vcbacked.co/company/pieriandx. Accessed September 29, 2026.
VCBacked. (2021). PierianDx — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/pieriandx
{{cite web |title=PierianDx — Funding & Investors |url=https://www.vcbacked.co/company/pieriandx |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated